Catalyst Wire Dossier Catalyst Wire Dossier

olinciguat

IW-1701 · Cyclerion Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for olinciguat, covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) [Phase 2]

See pricing